BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 17003238)

  • 21. Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin-1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscle.
    O'Neal P; Alamdari N; Smith I; Poylin V; Menconi M; Hasselgren PO
    J Cell Biochem; 2009 Nov; 108(4):963-73. PubMed ID: 19777444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin.
    Martin AI; Nieto-Bona MP; Castillero E; Fernandez-Galaz C; Lopez-Menduina M; Gomez-Sanmiguel AB; Gomez-Moreira C; Villanua MA; Lopez-Calderon A
    J Physiol Pharmacol; 2012 Dec; 63(6):649-59. PubMed ID: 23388481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.
    Castillero E; Alamdari N; Aversa Z; Gurav A; Hasselgren PO
    PLoS One; 2013; 8(3):e59726. PubMed ID: 23555761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice.
    De Naeyer H; Lamon S; Russell AP; Everaert I; De Spaey A; Vanheel B; Taes Y; Derave W
    Eur J Appl Physiol; 2014 Apr; 114(4):751-61. PubMed ID: 24390687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
    Baehr LM; Furlow JD; Bodine SC
    J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1.
    Gonnella P; Alamdari N; Tizio S; Aversa Z; Petkova V; Hasselgren PO
    J Cell Biochem; 2011 Jul; 112(7):1737-48. PubMed ID: 21381078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
    Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
    J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle.
    Smith IJ; Aversa Z; Alamdari N; Petkova V; Hasselgren PO
    J Cell Biochem; 2010 Nov; 111(4):1059-73. PubMed ID: 20677217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway.
    Gómez-SanMiguel AB; Villanúa MÁ; Martín AI; López-Calderón A
    PLoS One; 2016; 11(5):e0155645. PubMed ID: 27177152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.
    Granado M; Martín AI; Priego T; López-Calderón A; Villanúa MA
    J Endocrinol; 2006 Oct; 191(1):319-26. PubMed ID: 17065414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway.
    Martín AI; Gómez-SanMiguel AB; Gómez-Moreira C; Villanúa MÁ; López-Calderón A
    Mediators Inflamm; 2014; 2014():179368. PubMed ID: 25294954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice.
    Adams V; Mangner N; Gasch A; Krohne C; Gielen S; Hirner S; Thierse HJ; Witt CC; Linke A; Schuler G; Labeit S
    J Mol Biol; 2008 Dec; 384(1):48-59. PubMed ID: 18804115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression.
    Fareed MU; Evenson AR; Wei W; Menconi M; Poylin V; Petkova V; Pignol B; Hasselgren PO
    Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1589-97. PubMed ID: 16455766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
    Granado M; Martín AI; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
    Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
    PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors.
    Castillero E; Martín AI; López-Menduiña M; Villanúa MA; López-Calderón A
    Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1322-31. PubMed ID: 19741054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
    Edström E; Altun M; Hägglund M; Ulfhake B
    J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha.
    Lang CH; Frost RA
    Metabolism; 2007 Jan; 56(1):49-57. PubMed ID: 17161226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGF-1 is downregulated in experimental cancer cachexia.
    Costelli P; Muscaritoli M; Bossola M; Penna F; Reffo P; Bonetto A; Busquets S; Bonelli G; Lopez-Soriano FJ; Doglietto GB; Argilés JM; Baccino FM; Rossi Fanelli F
    Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R674-83. PubMed ID: 16614058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.